1. Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol 
Serkan Demirkan, MD, Özgür Gündüz, MD, Tuba Devrim, MD 
JAAD Case Reports 
Volume 3, Issue 4, Pages (July 2017)
DOI: /j.jdcr
Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Sorafenib-associated hand-foot syndrome. A and B, Hyperkeratosis and warty protrusions on palms and dorsum of hands. C and D, Total disapearence of the lesions after 2 weeks.
JAAD Case Reports 2017 3, DOI: ( /j.jdcr )
Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
Sorafenib-associated hand-foot syndrome. A, Prominent hyperkeratotic warty protrusions on toes. B, Partial remission of the lesions after 2 weeks.
JAAD Case Reports 2017 3, DOI: ( /j.jdcr )
Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

4. Fig 3
Epidermal hyperplasia, papillomatosis, and hyperkeratosis in epidermis (Hematoxylin-eosin stain; original magnification: ×10.)
JAAD Case Reports 2017 3, DOI: ( /j.jdcr )
Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions